A controlled study of tryptophan-benserazide in schizophrenia.
D000328:Adult; D000368:Aged; D001545:Benserazide / Q000009:adverse effects / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007737:Kynurenine / Q000097:blood; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D014364:Tryptophan / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D006834:Hydrazines; D007737:Kynurenine; D001545:Benserazide; D014364:Tryptophan; D002746:Chlorpromazine